Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Dec;21(12):1524-7.
doi: 10.1038/sj.eye.6702804. Epub 2007 Apr 20.

Intraocular use of rituximab

Affiliations
Case Reports

Intraocular use of rituximab

A S Kitzmann et al. Eye (Lond). 2007 Dec.

Abstract

Purpose: To evaluate the toxicity of 1 mg of intraocular rituximab and to present a small case-series of patients treated with intravitreal rituximab.

Methods: Rituximab (1 mg/0.1 ml) was injected in the vitreous of one eye of three Dutch-belted rabbits. Two animals were injected with balanced salt solution as controls. At 1 month the rabbits were killed and the eyes examined by light microscopy. Three patients (five eyes) with intraocular lymphoma were also treated with a 1 mg injection of rituximab.

Results: The treated rabbit eyes and the control eyes showed no light microscopic evidence of ocular toxicity at 1 month following injection. The five human eyes of three patients have shown no evidence of intraocular toxicity with a median follow-up time of 3.6 months (range 2.0-6.4 months). One patient received a total of four injections in the right eye and three injections in the left eye.

Conclusion: Intravitreal rituximab at a dose of 1 mg does not appear to cause toxicity in rabbit eyes and in the five eyes of three patients.

PubMed Disclaimer

Comment in

  • Intraocular rituximab.
    Singh AD, Peereboom DM. Singh AD, et al. Eye (Lond). 2007 Dec;21(12):1453-4. doi: 10.1038/sj.eye.6702976. Eye (Lond). 2007. PMID: 18159211 No abstract available.

Publication types

MeSH terms

LinkOut - more resources